PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
83 hedge funds and large institutions have $258M invested in Progenics Pharmaceuticals Inc in 2013 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
78% less call options, than puts
Call options by funds: $141K | Put options by funds: $638K
Holders
83
Holding in Top 10
–
Calls
$141K
Puts
$638K
Top Buyers
| 1 | +$3.24M | |
| 2 | +$1.7M | |
| 3 | +$1.57M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.28M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.25M |
Top Sellers
| 1 | -$2.58M | |
| 2 | -$2.31M | |
| 3 | -$1.42M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.22M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.11M |